Edition:
United Kingdom

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

10,850JPY
26 Mar 2019
Change (% chg)

¥490 (+4.73%)
Prev Close
¥10,360
Open
¥10,500
Day's High
¥10,900
Day's Low
¥10,500
Volume
160,100
Avg. Vol
110,194
52-wk High
¥14,130
52-wk Low
¥9,910

Select another date:

Wed, Dec 19 2018

Photo

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

UPDATE 2-Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion (1.3 billion pounds), the companies said on Wednesday.

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA - Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion (1.3-billion pound) deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

Dec 16 Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

Select another date: